Unknown

Dataset Information

0

Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.

ABSTRACT: The relationships between clonal architecture and functional heterogeneity in acute myeloid leukemia (AML) samples are not yet clear. We used targeted sequencing to track AML subclones identified by whole-genome sequencing using a variety of experimental approaches. We found that virtually all AML subclones trafficked from the marrow to the peripheral blood, but some were enriched in specific cell populations. Subclones showed variable engraftment potential in immunodeficient mice. Xenografts were predominantly comprised of a single genetically defined subclone, but there was no predictable relationship between the engrafting subclone and the evolutionary hierarchy of the leukemia. These data demonstrate the importance of integrating genetic and functional data in studies of primary cancer samples, both in xenograft models and in patients.

SUBMITTER: Klco JM 

PROVIDER: S-EPMC3983786 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The relationships between clonal architecture and functional heterogeneity in acute myeloid leukemia (AML) samples are not yet clear. We used targeted sequencing to track AML subclones identified by whole-genome sequencing using a variety of experimental approaches. We found that virtually all AML subclones trafficked from the marrow to the peripheral blood, but some were enriched in specific cell populations. Subclones showed variable engraftment potential in immunodeficient mice. Xenografts we  ...[more]

Similar Datasets

Unknown Heterogeneity in refractory acute myeloid leukemia.
| S-EPMC6535032 | biostudies-literature
Unknown Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.
| S-EPMC7124979 | biostudies-literature
Unknown Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
| S-EPMC4342352 | biostudies-literature
Unknown Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
| S-EPMC11002636 | biostudies-literature
Unknown Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity.
| S-EPMC7764578 | biostudies-literature
Unknown Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing.
| S-EPMC4091781 | biostudies-literature
Unknown Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.
| S-EPMC3735855 | biostudies-literature
Unknown Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.
| S-EPMC4349271 | biostudies-literature
Unknown Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.
| S-EPMC6925974 | biostudies-literature
Unknown Functional Classification of TP53 Mutations in Acute Myeloid Leukemia.
| S-EPMC7139772 | biostudies-literature